多発性骨髄腫におけるVinca Alkaloidの試用経験
スポンサーリンク
概要
- 論文の詳細を見る
There are many reports that Vinca alkaloid therapy is effective for leukemia in children, malignant lymphoma, etc. We applied this therapy to seven courses in six patients of multiple myeloma in which therapies with such agents as cyclophosphamide, steroid hormones, etc. had been ineffective. Of these seven courses, the therapy proved to be effective in three couses, but in the remaining four, inffective. In all courses, reduction of the peripheral leukocyte was observed as a side effect. Although this therapy may not be adopted as the first choice for multiple myeloma, it is considered as an alternative when other therapeutic regimens have been inffective.
- 一般社団法人 日本血液学会の論文
一般社団法人 日本血液学会 | 論文
- 健常者ならびに播種性血管内凝固(DIC)例における血漿アンチトロンビンIII (AT-III)の抗トロンビン活性と抗原性の比較
- 新生児の凝固・線溶阻止因子の動態
- All-trans retinoic acid投与中に広範な脳梗塞を生じた急性前骨髄球性白血病
- C/EBPβのショートアイソフォームであるLIPはマウス移植モデルにおいてEvi1と協調作用して急性骨髄性白血病を誘発する
- 成人に発症したビタミンK依存性血液凝固因子欠乏に関する臨床的解析